Sex;No. of nights spent away from home because of work/studies in the last 12 months;Perception of risk of infection of HIV/AIDS by injectable drugs;Total
Both sexes;Total;Total;20,759.6
Both sexes;Total;High risk;12,112.0
Both sexes;Total;Intermediate risk;2,041.3
Both sexes;Total;Low or no risk;96.7
Both sexes;Total;Depends on whether they share syringes or not;6,244.5
Both sexes;Total;No data recorded;265.2
Both sexes;At least 1 a month;Total;3,397.9
Both sexes;At least 1 a month;High risk;2,085.4
Both sexes;At least 1 a month;Intermediate risk;385.3
Both sexes;At least 1 a month;Low or no risk;23.1
Both sexes;At least 1 a month;Depends on whether they share syringes or not;862.8
Both sexes;At least 1 a month;No data recorded;41.3
Both sexes;Less than 1 a month;Total;17,246.1
Both sexes;Less than 1 a month;High risk;9,964.9
Both sexes;Less than 1 a month;Intermediate risk;1,638.3
Both sexes;Less than 1 a month;Low or no risk;71.8
Both sexes;Less than 1 a month;Depends on whether they share syringes or not;5,357.3
Both sexes;Less than 1 a month;No data recorded;213.7
Both sexes;No data recorded;Total;115.7
Both sexes;No data recorded;High risk;61.7
Both sexes;No data recorded;Intermediate risk;17.6
Both sexes;No data recorded;Low or no risk;1.8
Both sexes;No data recorded;Depends on whether they share syringes or not;24.3
Both sexes;No data recorded;No data recorded;10.2
Males;Total;Total;10,532.1
Males;Total;High risk;6,158.8
Males;Total;Intermediate risk;1,216.2
Males;Total;Low or no risk;70.6
Males;Total;Depends on whether they share syringes or not;2,939.4
Males;Total;No data recorded;147.1
Males;At least 1 a month;Total;2,279.2
Males;At least 1 a month;High risk;1,383.8
Males;At least 1 a month;Intermediate risk;285.5
Males;At least 1 a month;Low or no risk;18.9
Males;At least 1 a month;Depends on whether they share syringes or not;564.6
Males;At least 1 a month;No data recorded;26.4
Males;Less than 1 a month;Total;8,193.6
Males;Less than 1 a month;High risk;4,741.3
Males;Less than 1 a month;Intermediate risk;920.9
Males;Less than 1 a month;Low or no risk;49.8
Males;Less than 1 a month;Depends on whether they share syringes or not;2,363.6
Males;Less than 1 a month;No data recorded;117.9
Males;No data recorded;Total;59.4
Males;No data recorded;High risk;33.7
Males;No data recorded;Intermediate risk;9.8
Males;No data recorded;Low or no risk;1.8
Males;No data recorded;Depends on whether they share syringes or not;11.2
Males;No data recorded;No data recorded;2.8
Females;Total;Total;10,227.5
Females;Total;High risk;5,953.2
Females;Total;Intermediate risk;825.0
Females;Total;Low or no risk;26.2
Females;Total;Depends on whether they share syringes or not;3,305.0
Females;Total;No data recorded;118.1
Females;At least 1 a month;Total;1,118.7
Females;At least 1 a month;High risk;701.6
Females;At least 1 a month;Intermediate risk;99.8
Females;At least 1 a month;Low or no risk;4.2
Females;At least 1 a month;Depends on whether they share syringes or not;298.2
Females;At least 1 a month;No data recorded;14.9
Females;Less than 1 a month;Total;9,052.5
Females;Less than 1 a month;High risk;5,223.6
Females;Less than 1 a month;Intermediate risk;717.4
Females;Less than 1 a month;Low or no risk;22.0
Females;Less than 1 a month;Depends on whether they share syringes or not;2,993.7
Females;Less than 1 a month;No data recorded;95.8
Females;No data recorded;Total;56.3
Females;No data recorded;High risk;28.0
Females;No data recorded;Intermediate risk;7.7
Females;No data recorded;Low or no risk;0.0
Females;No data recorded;Depends on whether they share syringes or not;13.1
Females;No data recorded;No data recorded;7.4